Spleen tyrosine kinase (SYK) inhibitors, including Tavalisse (fostamatinib disodium hexahydrate), may be effective treatments for…
Articles by Marisa Wexler MS
The case of a woman with von Willebrand disease type 1 who developed a ruptured brain aneurysm was described…
Pharma companies Galapagos and Gilead are in talks for a potential collaboration to develop gamgertamig, an experimental therapy…
Celebrities and advocacy groups are teaming up to raise awareness of bleeding disorders with a three-hour livestream celebrating the community.
A group of U.S. treatment centers worked together to standardize care for children with immune thrombocytopenia (ITP), leading to…
A recent report describes the case of a woman with acquired thrombotic thrombocytopenic purpura (TTP) who was later found…
HMB-002, an antibody-based experimental treatment for von Willebrand disease (VWD) currently in early clinical testing, boosted levels of the…
A combination of the medicines eltrombopag and cyclosporine A may be effective for controlling immune thrombocytopenia (ITP) that doesn’t…
A recent case report highlights the challenges of performing surgery in a patient with more than one bleeding disorder. Two…
The approved immune thrombocytopenia (ITP) treatment Doptelet (avatrombopag) may be able to be repurposed to treat certain bone…